Compile Data Set for Download or QSAR
maximum 50k data
Found 50 of Enz. Inhib. data with enzyme = 'Acetylcholinesterase' and Substrate = 'to-be-curated'
TargetAcetylcholinesterase(Rattus norvegicus (rat))
Pudue Pharma Discovery Research

Curated by PDSP Ki Database
LigandPNGBDBM50133817(4-(3-Chloro-pyridin-2-yl)-piperazine-1-carboxylic ...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM8960((+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimet...)
Affinity DataIC50:  8nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM8960((+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimet...)
Affinity DataIC50:  11nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327448(1-(4-amino-5-fluoro-2-methoxyphenyl)-3-[1-(cyclohe...)
Affinity DataIC50:  24nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327447(1-(4-amino-2-methoxyphenyl)-3-[1-(cyclohexylmethyl...)
Affinity DataIC50:  26nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079366(CHEMBL3416997 | US9663465, 12)
Affinity DataIC50:  57nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079362(CHEMBL3417009 | US9663465, 9)
Affinity DataIC50:  63nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079365(CHEMBL3416996 | US9663465, 8)
Affinity DataIC50:  69nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327457(1-(4-amino-5-bromo-2-methoxyphenyl)-3-[1-(cyclohex...)
Affinity DataIC50:  99nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327456(1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-[(piperi...)
Affinity DataIC50:  118nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327453(1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohe...)
Affinity DataIC50:  201nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079368(CHEMBL3416999 | US9663465, 16)
Affinity DataIC50:  222nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327458( 1-(4-amino-5-iodo-2-methoxyphenyl)-3-[1-(cyclohex...)
Affinity DataIC50:  304nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327467( 2-chloro-4-[[2-[1-(cyclohexylmethyl)-4-piperidyl]...)
Affinity DataIC50:  320nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079369(CHEMBL3417000 | US9663465, 11)
Affinity DataIC50:  321nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327465(1-(4-amino-5-chloro-2-éthoxyphenyl)-3-[1-(cyclohex...)
Affinity DataIC50:  395nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327464(1-(4-amino-5-chloro-2-hydroxyphenyl)-3-[1-(cyclohe...)
Affinity DataIC50:  411nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327445(1-(4-amino-5-bromo-2-methoxyphenyl)-3-[1-butyl-4-p...)
Affinity DataIC50:  445nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079364(CHEMBL3416995 | US9663465, 7)
Affinity DataIC50:  577nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327466(1-[4-amino-5-chloro-2-(2-fluoroéthoxy)phenyl]-3-[1...)
Affinity DataIC50:  625nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327446(1-(4-amino-5-iodo-2-methoxyphenyl)-3-[1-butyl-4-pi...)
Affinity DataIC50:  658nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM10404((1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetrac...)
Affinity DataIC50:  700nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327444(1-(4-amino-2-methoxyphenyl)-3-[1-butyl-4-piperidyl...)
Affinity DataIC50:  748nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079363(CHEMBL3414597 | US9663465, 6)
Affinity DataIC50:  937nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50079375(CHEMBL3417008 | US9663465, 20)
Affinity DataIC50:  2.72E+3nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294221((±)-3-(1-(dimethylamino)ethyl)-1-methoxy-6H-benzo[...)
Affinity DataIC50:  2.80E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327460(4-amino-5-chloro-[[1-(cyclohexylmethyl)-4-piperidy...)
Affinity DataIC50:  3.73E+3nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327462( 4-amino-5-iodo-N-[[1-(cyclohexylmethyl)-4-piperid...)
Affinity DataIC50:  5.09E+3nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294220((S)-3-(1-(dimethylamino)ethyl)-6H-benzo[c]chromen-...)
Affinity DataIC50:  7.90E+3nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM327461(4-amino-5-bromo-N-[[1-(cyclohexylmethyl)-4-piperid...)
Affinity DataIC50:  8.70E+3nMAssay Description:Acetylcholinesterase extracted from human erythrocytes (buffered aqueous solution, ≧500 units/mg, Sigma Aldrich) is diluted in a 20 mM HEPES bu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294219((±)-3-(1-(dimethylamino)ethyl)-6H-benzo[c]chromen-...)
Affinity DataIC50:  1.09E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294222((±)-1-(1-(dimethylamino)ethyl)-3-methoxy-6H-benzo[...)
Affinity DataIC50:  1.51E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294223((±)-3-(1-(dimethylamino)ethyl)-1-hydroxy-6H-benzo[...)
Affinity DataIC50:  1.89E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293405(US10106521, Compound 14-O-Benzyl Phlorofucofuroeck...)
Affinity DataIC50:  2.32E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50259983(CHEMBL508791 | US10106521, Compound Dieckol | diec...)
Affinity DataIC50:  2.34E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294224((±)-1-(1-(dimethylamino)ethyl)-3-hydroxy-6H-benzo[...)
Affinity DataIC50:  3.31E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293401(US10106521, Compound 9''-O-Methyl Dieckol)
Affinity DataIC50:  3.32E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293398(US10106521, Compound 9-O-Methyl Eckol)
Affinity DataIC50:  3.42E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM11682(2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethyl...)
Affinity DataIC50:  3.52E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294226((±)-1-(1-(dimethylamino)ethyl)-6-oxo-6H-benzo[c]ch...)
Affinity DataIC50: >4.00E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM294225((±)-3-(1-(dimethylamino)ethyl)-6-oxo-6H-benzo[c]ch...)
Affinity DataIC50:  4.00E+4nMAssay Description:The potential of the compounds of the present invention to inhibit acetylcholinesterase and butyrylcholinesterase enzymes were tested according to th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293399(US10106521, Compound 9-O-Benzyl Eckol)
Affinity DataIC50:  4.01E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293402(US10106521, Compound 9''-O-Benzyl Dieckol)
Affinity DataIC50:  4.19E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50259982(CHEMBL471187 | US10106521, Compound Eckol | eckol)
Affinity DataIC50:  4.51E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM293404(US10106521, Compound 14-O-Methyl Phlorofucofuroeck...)
Affinity DataIC50:  6.56E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM50276756(4,9-bis(3,5-dihydroxyphenoxy)benzofuro[3,2-a]diben...)
Affinity DataIC50:  9.41E+4nMpH: 7.4 T: 2°CAssay Description:Enzyme activities were determined at room temperature. Ultraviolet absorbance was measured spectrophotometrically by a modification of a previously d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM476179((−)-N1, N8-bisnorphenylcarbamoyleseroline | ...)
Affinity DataEC50:  100nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM10958((3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyr...)
Affinity DataEC50:  25nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM476174((−)-N1-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Nobel IlaÇ

US Patent
LigandPNGBDBM476178((−)-N8-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In DepthDetails US Patent